Role of magnetic resonance spectroscopic imaging ([1H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA)

The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels

(2009) Nathan Lawrentschuk et al.   BJU INTERNATIONAL

Functional Magnetic Resonance Imaging in Prostate Cancer

(2009) Michael Seitz et al.   EUROPEAN UROLOGY

Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours

(2008) S. Cirillo et al.   CLINICAL RADIOLOGY

2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation

(2008) Valeria Panebianco et al.   EUROPEAN RADIOLOGY

Proton Spectroscopic and Dynamic Contrast-Enhanced Magnetic Resonance: A Modern Approach in Prostate Cancer Imaging

(2008) Alessandro Sciarra et al.   EUROPEAN UROLOGY

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience

(2008) M. Carlani et al.   Radiologia Medica

Biopsy-Derived Gleason Artifact and Prostate Volume: Experience Using Ten Samples in Larger Prostates

(2008) Alessandro Sciarra et al.   UROLOGIA INTERNATIONALIS

Potential of Magnetic Resonance Spectroscopic Imaging in Predicting Absence of Prostate Cancer in Men With Serum Prostate-Specific Antigen Between 4 and 10 ng/mL: A Follow-up Study

(2008) Rajeev Kumar et al.   UROLOGY

EAU Guidelines on Prostate Cancer

(2007) Axel Heidenreich et al.   EUROPEAN UROLOGY